MMP2 and cancer: In several clinical trials targeting MMP2, drugs such as Marimastat (BB-2516), Prinomastat (AG3340), and Tanomastat (BAY 12-9566) were designed to inhibit MMP2 activity with the aim of suppressing cancer progression 45.